Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to study ST000549 main page
Show: (1)
HMDB and KEGG pathways
(2)
REACTOME pathways
containing these metabolites
Select
Metabolite Name
Metabolite Id
Refmet Name
Ret. Index
Quant. m/z
Analysis Display
2-Hydroxyfelbamate
ME163506
2-Hydroxyfelbamate
0.8285713
-
HILIC NEGATIVE ION MODE
3-Sulfocatechol
ME163451
3-Sulfocatechol
0.731612
-
HILIC NEGATIVE ION MODE
5-Sulfosalicylic acid
ME163537
5-Sulfosalicylic acid
0.86550575
-
HILIC NEGATIVE ION MODE
5-Sulfosalicylic acid - 0.97004646
ME163585
5-Sulfosalicylic acid
0.97004646
-
HILIC NEGATIVE ION MODE
5-Sulfosalicylic acid - 1.5343589
ME163899
5-Sulfosalicylic acid
1.5343589
-
HILIC NEGATIVE ION MODE
doxylamine
ME163580
Doxylamine
0.9955655
-
HILIC NEGATIVE ION MODE
Ferimzone
ME163800
Ferimzone
1.1578294
-
HILIC NEGATIVE ION MODE
Fexofenadine
ME164174
Fexofenadine
5.5387588
-
HILIC NEGATIVE ION MODE
Fexofenadine - 5.6491313
ME164185
Fexofenadine
5.6491313
-
HILIC NEGATIVE ION MODE
Ginkgolic Acid
ME163672
Ginkgolic acid
1.0937707
-
HILIC NEGATIVE ION MODE
Ingenol 3,20-dibenzoate
ME163950
Ingenol 3,20-dibenzoate
1.713355
-
HILIC NEGATIVE ION MODE
1,2,3-Trimethylbenzene
ME161460
1,2,3-Trimethylbenzene
1.1510674
-
HILIC POSITIVE ION MODE
2,4-Dihydroxybenzophenone
ME161831
2,4-Dihydroxybenzophenone
1.7193168
-
HILIC POSITIVE ION MODE
2-Hydroxyfelbamate
ME162541
2-Hydroxyfelbamate
6.4073725
-
HILIC POSITIVE ION MODE
4-Nitroaniline
ME161846
4-Nitroaniline
1.7614093
-
HILIC POSITIVE ION MODE
4-Nitroaniline + 2.7460015
ME161960
4-Nitroaniline
2.7460015
-
HILIC POSITIVE ION MODE
4-Nitroaniline + 3.668444
ME162021
4-Nitroaniline
3.668444
-
HILIC POSITIVE ION MODE
Aureothin
ME162916
Aureothin
8.283623
-
HILIC POSITIVE ION MODE
Convoline
ME161916
Convoline
2.1635633
-
HILIC POSITIVE ION MODE
Dextroamphetamine
ME163092
Dextroamphetamine
3.4751046
-
HILIC POSITIVE ION MODE
Dibutyl phthalate
ME161252
Dibutyl phthalate
1.0597287
-
HILIC POSITIVE ION MODE
Diisooctyl phthalate
ME161230
Diisooctyl phthalate
1.0447284
-
HILIC POSITIVE ION MODE
Erythrohydrobupropion
ME162115
Erythrohydrobupropion
4.3161874
-
HILIC POSITIVE ION MODE
Ferimzone
ME161361
Ferimzone
1.1297677
-
HILIC POSITIVE ION MODE
Ferimzone + 1.587867
ME163057
Ferimzone
1.587867
-
HILIC POSITIVE ION MODE
Fexofenadine
ME162303
Fexofenadine
5.5354357
-
HILIC POSITIVE ION MODE
Fexofenadine + 5.6458764
ME162333
Fexofenadine
5.6458764
-
HILIC POSITIVE ION MODE
Gallopamil
ME163129
Gallopamil
5.9701333
-
HILIC POSITIVE ION MODE
l-Methamphetamine
ME162071
Methamphetamine
4.148058
-
HILIC POSITIVE ION MODE
Mephentermine
ME162050
Mephentermine
4.0012
-
HILIC POSITIVE ION MODE
Methylnoradrenaline
ME163400
Levonordefrin
0.8957567
-
HILIC POSITIVE ION MODE
Monuron
ME162040
Monuron
3.8713799
-
HILIC POSITIVE ION MODE
Nadolol
ME163279
Nadolol
6.3468485
-
HILIC POSITIVE ION MODE
Nadolol + 6.457579
ME163280
Nadolol
6.457579
-
HILIC POSITIVE ION MODE
p-Aminobenzoic acid
ME162776
p-Aminobenzoic acid
7.046158
-
HILIC POSITIVE ION MODE
p-Aminobenzoic acid + 7.2129807
ME162822
p-Aminobenzoic acid
7.2129807
-
HILIC POSITIVE ION MODE
Propofol
ME161606
Propofol
1.2552315
-
HILIC POSITIVE ION MODE
Fexofenadine
ME164714
Fexofenadine
11.028918
-
Reversed phase POSITIVE ION MODE
p-Aminobenzoic acid
ME164739
p-Aminobenzoic acid
0.99348116
-
Reversed phase POSITIVE ION MODE
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
Terms of use
Site map
Contact
NMDR Personnel